| 产品编号 |
产品名称 |
序列 |
别称 |
CAS Number |
分子式 |
分子量 |
疾病类 |
包装 |
| CS9404 |
NEB0, Exendin-4
|
序列
|
|
|
|
4811.21 |
|
|
| NEB-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 |
| CS9408 |
5-Azidovalerianic acid0, Octreotide
|
序列
|
|
|
|
|
|
|
| (5-Azidovalerianic acid)-(D-Phe)-Cys-Phe-(D-Trp)-Lys-Thr-Cys-Thr-Ol (Disulfide bond Cys2/Cys7) |
| CS9409 |
DOTA, (1-Nal)3-Octreotide
|
序列
|
|
|
C69H92N14O17S2 |
1453.6 |
|
|
| DOTA-(D-Phe)-Cys-(1-Nal)-(D-Trp)-Lys-Thr-Cys-Thr-ol (Disulfide bond Cys2/Cys7) |
| CS9411 |
Glicentin (21-89)
|
序列
|
|
|
C340H532N108O119S2 |
8101.05 |
|
|
| Arg-Ser-Leu-Gln-Asp-Thr-Glu-Glu-Lys-Ser-Arg-Ser-Phe-Ser-Ala-Ser-Gln-Ala-Asp-Pro-Leu-Ser-Asp-Pro-Asp-Gln-Met-Asn-Glu-Asp-Lys-Arg-His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-Lys-Arg-Asn-Arg-Asn-Asn-Ile-Ala |
| CS9412 |
NMe-D-Orn(AMBS-NOTA)2, CPCR4-2
|
序列
|
|
|
C56H73N13O12 |
1120.28 |
|
|
| Cyclo[(D-Tyr)-(NMe-D-Orn)-(AMBS-NOTA)-Arg-(2-Nal)-Gly] [Cyclo(D-Tyr)1/Gly5] |
| CS9413 |
3PRGD2
|
序列
|
|
|
|
2060.34 |
|
|
| PEG4-Glu-{PEG4-cyclo[Arg-Gly-Asp-(D-Tyr)-Lys]}2 |
| CS9414 |
Biotin0, Semaglutide
|
序列
|
|
|
|
|
|
|
| Biotin-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys[AEEA-AEEA-(γ-Glu)-17-Carboxyheptadecanic acid]-Glu-Phe-lle-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly |
| CS9416 |
(D-Glu)2, 3PRGD2
|
序列
|
|
|
|
|
|
|
| PEG4-(D-Glu)-{PEG4-cyclo[Arg-Gly-Asp-(D-Tyr)-Lys]}2 |
| CS9417 |
Hynic0, (D-Glu)2, 3PRGD2
|
序列
|
|
|
|
|
|
|
| Hynic-PEG4-(D-Glu)-{PEG4-cyclo[(D-Arg)-Gly-(D-Asp)-Phe-(D-Lys)]}2 |
| CS9418 |
NOTA-3PRGD2
|
序列
|
|
|
|
2500.84 |
|
|
| NOTA-PEG4-Glu{PEG4-cyclo[Arg-Gly-Asp-(D-Tyr)-Lys]}2 |
| CS9419 |
CXCR301
|
序列
|
|
|
C36H47N9O6 |
701.8 |
|
|
| Cyclo[(D-Tyr)-(NMe-D-Orn)-Arg-(2-Nal)-Gly] [Cyclo(D-Tyr)1/Gly5] |
| CS9420 |
Exendin-4 (5-39)
|
序列
|
|
|
C169H262N44O54S |
3806.3 |
|
|
| Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 |
| CS9422 |
Bivalirudin (1-11)
|
序列
|
|
|
|
|
|
|
| (D-Phe)-Pro-Arg-Pro-Gly-Gly-Gly-Gly-Asn-Gly-Asp |
| CS9423 |
Bivalirudin (3-20)
|
序列
|
|
|
|
|
|
|
| Arg-Pro-Gly-Gly-Gly-Gly-Asn-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu |
| CS9424 |
Asp11(cycloimido), Bivalirudin
|
序列
|
|
|
|
|
|
|
| (D-Phe)-Pro-Arg-Pro-Gly-Gly-Gly-Gly-Asn-Gly-Asp(cycloimido)-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu |
| CS9425 |
Pasireotide
|
序列
|
|
|
|
|
|
|
| Cyclo[Tyr(4-Bzl)-Phe-Hyp(NH2CH2CH2NHCO)-Phg-(D-Trp)-Lys] |
| CS9426 |
Penetratin-eiF4E
|
序列
|
|
|
C215H344N66O57S |
4797.78 |
|
|
| (D-Arg)-(D-Gln)-(D-Ile)-(D-Lys)-(D-Ile)-(D-Trp)-(D-Phe)-(D-Gln)-(D-Asn)-(D-Arg)-(D-Arg)-(D-Met)-(D-Lys)-(D-Trp)-(D-Lys)-(D-Lys)-Ile-Gly-Tyr-Gln-Ser-His-Ala-Asp-Thr-Ala-Thr-Lys-Ser-Gly-Ser-Thr-Thr-Lys-Asn-Arg-Phe-Val-Val |
| CS9427 |
Palmitoyl Tripeptide
|
序列
|
|
|
C33H63N5O5 |
609.9 |
|
|
| Palmitoyl-Lys-Pro-Lys |
| CS9428 |
hPTHrP (1-36)
|
序列
|
|
|
C191H305N59O52 |
4260.1 |
|
|
| Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Ile |
| CS9429 |
Peg3, Bombesin (7-14)
|
序列
|
|
|
|
1143.34 |
|
|
| PEG3-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 |
沪公网安备 31011502005552号
沪ICP备13005633号-1